MedTrace Logo

MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids

NCT00166270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-07-09

No results posted yet for this study

Summary

This is a prospective, nonrandomized, multi-center study to evaluate the safety and effectiveness of ExAblate in the treatment of uterine fibroids. All patients will be treated and then followed for 36 months to evaluate the change in their fibroid symptoms.

Conditions

  • Uterine Fibroids

Interventions

DEVICE

ExAblate 2000

Sponsors & Collaborators

  • InSightec

    lead INDUSTRY

Principal Investigators

  • Phyllis Gee, M.D. · North Texas UFI

  • Paul Curtis, M.D. · Virtua

  • George Holland, M.D. · Lahey Clinic

  • Dennis Sarti, M.D. · Radnet Management

  • Fred Steinberg, M.D. · Univeristy MRI

  • Elizabeth Stewart, M.D. · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2006-04-30
Completion
2009-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00166270 on ClinicalTrials.gov